Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest Biotech Health services Investments 16 October 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 157M Round investors: HealthCapNovo A/SSofinnova PartnersDeep Track CapitalAccess BiotechnologyMaj InvestRA Capital ManagementAvoro CapitalInvus Company: Hemab Industry: BiotechHealth services
Flatpay in a €145 million Series D round with investors including Dawn Capital, AVP and Smash Capital. Hardware Mobile payments Payment processing Software Services Investments 01 November 2025
AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion Biotech Health services Investments 19 October 2025
ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion Biotech Health services Pharma M&A 12 October 2025
Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital, Biotech Health services Investments 03 October 2025